Technical Analysis for CYAD - Celyad SA

Grade Last Price % Change Price Change
grade D 22.6 0.27% 0.06
CYAD closed up 0.27 percent on Wednesday, March 20, 2019, on 1.2 times normal volume.

Earnings due: Mar 28

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CYAD trend table...

Date Alert Name Type % Chg
Mar 20 Bollinger Band Squeeze Range Contraction 0.00%
Mar 20 Upper Bollinger Band Walk Strength 0.00%
Mar 20 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Mar 20 Inside Day Range Contraction 0.00%
Mar 20 Above Upper BB Strength 0.00%
Mar 20 Up 3 Days in a Row Strength 0.00%
Mar 20 Up 4 Days in a Row Strength 0.00%
Mar 20 Up 5 Days in a Row Strength 0.00%
Mar 20 Upper Bollinger Band Touch Strength 0.00%
Mar 19 Pocket Pivot Bullish Swing Setup 0.27%

Older signals for CYAD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure, allows the differentiation of a patient's own cells into cardiopoeitic cells which grow into new heart cells and repair heart muscle. C-Cure consists of autologous adult stem cells guided in vitro to the cardiac lineage before implantation in the failing heart. Furthermore, the Company is involved in the field of immuno-oncology, through its subsidiary, OnCyte.
Biotechnology Life Sciences Biology Stem Cells Cardiovascular Disease Stem Cell Therapy Induced Stem Cells Adult Stem Cell
Is CYAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.5
52 Week Low 15.36
Average Volume 4,541
200-Day Moving Average 25.5245
50-Day Moving Average 21.5673
20-Day Moving Average 21.1178
10-Day Moving Average 21.4985
Average True Range 0.6834
ADX 24.22
+DI 30.0997
-DI 10.6792
Chandelier Exit (Long, 3 ATRs ) 20.9398
Chandelier Exit (Short, 3 ATRs ) 22.0502
Upper Bollinger Band 22.4336
Lower Bollinger Band 19.802
Percent B (%b) 1.06
BandWidth 12.461525
MACD Line 0.266
MACD Signal Line 0.0546
MACD Histogram 0.2115
Fundamentals Value
Market Cap 215.27 Million
Num Shares 9.53 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -8.37
Price-to-Sales 41.08
Price-to-Book 6.10
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.19
Resistance 3 (R3) 23.12 22.86 23.09
Resistance 2 (R2) 22.86 22.71 22.89 23.05
Resistance 1 (R1) 22.73 22.62 22.80 22.80 23.02
Pivot Point 22.47 22.47 22.50 22.50 22.47
Support 1 (S1) 22.34 22.32 22.41 22.41 22.18
Support 2 (S2) 22.08 22.23 22.11 22.15
Support 3 (S3) 21.95 22.08 22.11
Support 4 (S4) 22.02